Barinthus Biotherapeutics plc Cash Flow Reinvestment Rate

Latest as of December 2024: 0.04x

Barinthus Biotherapeutics plc cash flow reinvestment rate. Barinthus Biotherapeutics plc (BRNS) has a Cash Flow Reinvestment Rate of 0.04x as of December 2024, reinvesting $556.00K (capex $278.00K plus investments $-278.00K) from operating cash flow of $13.09 Million. Explore how well can Barinthus Biotherapeutics plc service its debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.04x

(Capex + Investments) / Operating CF

Total Reinvested

$556.00K

Capex + Investments

Operating Cash Flow

$13.09 Million

USD

Capital Expenditures

$278.00K

USD

Barinthus Biotherapeutics plc Cash Flow Reinvestment Rate by Year (None–None)

Barinthus Biotherapeutics plc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Barinthus Biotherapeutics plc. For the full cash flow conversion analysis, see cash efficiency ratio of Barinthus Biotherapeutics plc.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow